{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T06:00:43Z","timestamp":1789192843129,"version":"build-2803163510"},"reference-count":150,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"DOI":"10.1007\/s11011-024-01431-7","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T07:50:28Z","timestamp":1732780228000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Blood-based microRNAs as the potential biomarkers for Alzheimer\u2019s disease: evidence from a systematic review"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-2680-1424","authenticated-orcid":false,"given":"Fateme","family":"Fattahi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7055-9550","authenticated-orcid":false,"given":"Mohammad Reza","family":"Asadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samin","family":"Abed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghazal","family":"Kouchakali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoumeh","family":"Kazemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3398-941X","authenticated-orcid":false,"given":"Sima","family":"Mansoori Derakhshan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4660-0530","authenticated-orcid":false,"given":"Mahmoud","family":"Shekari Khaniani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,28]]},"reference":[{"key":"1431_CR1","doi-asserted-by":"crossref","unstructured":"Abolghasemi M, Poursaei E, Bornehdeli S, Shanehbandi D, Asadi M, Sadeghzadeh M, Sadeh RN (2021) Exploration of potential circulating micro-RNA as biomarker for Alzheimer\u2019s disease. Meta Gene 30:100968","DOI":"10.1016\/j.mgene.2021.100968"},{"issue":"10","key":"1431_CR2","doi-asserted-by":"publisher","first-page":"4156","DOI":"10.1007\/s12035-020-02013-1","volume":"57","author":"A Aharon","year":"2020","unstructured":"Aharon A et al (2020) Extracellular vesicles of Alzheimer\u2019s disease patients as a biomarker for disease progression. Mol Neurobiol 57(10):4156\u20134169","journal-title":"Mol Neurobiol"},{"key":"1431_CR3","doi-asserted-by":"crossref","unstructured":"Arroyo JD et al (2011) Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci 108(12):5003\u20135008","DOI":"10.1073\/pnas.1019055108"},{"key":"1431_CR4","doi-asserted-by":"publisher","first-page":"933019","DOI":"10.3389\/fnagi.2022.933019","volume":"14","author":"MR Asadi","year":"2022","unstructured":"Asadi MR et al (2022) Analysis of ROQUIN, Tristetraprolin (TTP), and BDNF\/miR-16\/TTP regulatory axis in late onset Alzheimer\u2019s disease. Front Aging Neurosci 14:933019","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"1431_CR5","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jalz.2019.01.010","volume":"15","author":"As Association","year":"2019","unstructured":"Association As (2019) 2019 Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s Dement 15(3):321\u2013387","journal-title":"Alzheimer\u2019s Dement"},{"key":"1431_CR6","doi-asserted-by":"publisher","first-page":"1228927","DOI":"10.3389\/fnins.2023.1228927","volume":"17","author":"B Awuson-David","year":"2023","unstructured":"Awuson-David B et al (2023) Common microRNA regulated pathways in Alzheimer\u2019s and Parkinson\u2019s disease. Front NeuroSci 17:1228927","journal-title":"Front NeuroSci"},{"key":"1431_CR7","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.exger.2017.10.023","volume":"100","author":"T Baluchnejadmojarad","year":"2017","unstructured":"Baluchnejadmojarad T et al (2017) The anti-aging protein klotho alleviates injury of nigrostriatal dopaminergic pathway in 6-hydroxydopamine rat model of Parkinson\u2019s disease: involvement of PKA\/CaMKII\/CREB signaling. Exp Gerontol 100:70\u201376","journal-title":"Exp Gerontol"},{"key":"1431_CR8","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s10571-019-00751-y","volume":"40","author":"C Barbagallo","year":"2020","unstructured":"Barbagallo C et al (2020) Specific signatures of serum miRNAs as potential biomarkers to discriminate clinically similar neurodegenerative and vascular-related diseases. Cell Mol Neurobiol 40:531\u2013546","journal-title":"Cell Mol Neurobiol"},{"issue":"10","key":"1431_CR9","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/nrn2494","volume":"9","author":"L Bertram","year":"2008","unstructured":"Bertram L, Tanzi RE (2008) Thirty years of Alzheimer\u2019s disease genetics: the implications of systematic meta-analyses. Nat Rev Neurosci 9(10):768\u2013778","journal-title":"Nat Rev Neurosci"},{"issue":"8","key":"1431_CR10","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1002\/humu.21027","volume":"30","author":"K Bettens","year":"2009","unstructured":"Bettens K et al (2009) APP and BACE1 miRNA genetic variability has no major role in risk for Alzheimer disease. Hum Mutat 30(8):1207\u20131213","journal-title":"Hum Mutat"},{"key":"1431_CR11","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3389\/fnmol.2014.00002","volume":"7","author":"S Bhatnagar","year":"2014","unstructured":"Bhatnagar S et al (2014) Increased microRNA-34c abundance in Alzheimer\u2019s disease circulating blood plasma. Front Mol Neurosci 7:2","journal-title":"Front Mol Neurosci"},{"issue":"4","key":"1431_CR12","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1111\/jam.14264","volume":"127","author":"M Bostanciklio\u011flu","year":"2019","unstructured":"Bostanciklio\u011flu M (2019) The role of gut microbiota in pathogenesis of Alzheimer\u2019s disease. J Appl Microbiol 127(4):954\u2013967","journal-title":"J Appl Microbiol"},{"key":"1431_CR13","doi-asserted-by":"publisher","first-page":"760567","DOI":"10.3389\/fnins.2021.760567","volume":"15","author":"S Bu","year":"2021","unstructured":"Bu S et al (2021) Zinc finger proteins in neuro-related diseases progression. Front NeuroSci 15:760567","journal-title":"Front NeuroSci"},{"key":"1431_CR14","doi-asserted-by":"crossref","unstructured":"Chang W-S et al (2017) Genome-wide profiling of miRNA and mRNA expression in Alzheimer\u2019s disease. Med Sci Monit Int Med J Exp Clin Res 23:2721","DOI":"10.12659\/MSM.905064"},{"issue":"9","key":"1431_CR15","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1210\/jc.2017-00619","volume":"102","author":"S Chopra","year":"2017","unstructured":"Chopra S et al (2017) Obstructive sleep apnea dynamically increases nocturnal plasma free fatty acids, glucose, and cortisol during sleep. J Clin Endocrinol Metab 102(9):3172\u20133181","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"2","key":"1431_CR16","doi-asserted-by":"publisher","first-page":"68","DOI":"10.4103\/2229-3485.179431","volume":"7","author":"AF Christopher","year":"2016","unstructured":"Christopher AF et al (2016) MicroRNA therapeutics: discovering novel targets and developing specific therapy. Perspect Clin Res 7(2):68\u201374","journal-title":"Perspect Clin Res"},{"key":"1431_CR17","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s12031-018-1231-y","volume":"67","author":"CEL Chua","year":"2019","unstructured":"Chua CEL, Tang BL (2019) miR-34a in neurophysiology and neuropathology. J Mol Neurosci 67:235\u2013246","journal-title":"J Mol Neurosci"},{"issue":"16","key":"1431_CR18","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1101\/gad.340305","volume":"19","author":"F Clotman","year":"2005","unstructured":"Clotman F et al (2005) Control of liver cell fate decision by a gradient of TGF\u03b2 signaling modulated by Onecut transcription factors. Genes Dev 19(16):1849\u20131854","journal-title":"Genes Dev"},{"issue":"23","key":"1431_CR19","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1101\/gad.200758.112","volume":"26","author":"AR Colas","year":"2012","unstructured":"Colas AR et al (2012) Whole-genome microRNA screening identifies let-7 and mir-18 as regulators of germ layer formation during early embryogenesis. Genes Dev 26(23):2567\u20132579","journal-title":"Genes Dev"},{"issue":"11","key":"1431_CR20","doi-asserted-by":"publisher","first-page":"4408","DOI":"10.1007\/s12035-020-02029-7","volume":"57","author":"B De Felice","year":"2020","unstructured":"De Felice B et al (2020) MicroRNA expression signature in mild cognitive impairment due to Alzheimer\u2019s Disease. Mol Neurobiol 57(11):4408\u20134416","journal-title":"Mol Neurobiol"},{"issue":"2","key":"1431_CR21","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.nbd.2012.01.003","volume":"46","author":"C Delay","year":"2012","unstructured":"Delay C, Mandemakers W, H\u00e9bert SS (2012) MicroRNAs in Alzheimer\u2019s disease. Neurobiol Dis 46(2):285\u2013290","journal-title":"Neurobiol Dis"},{"issue":"9","key":"1431_CR22","first-page":"5752","volume":"12","author":"Z Deng","year":"2020","unstructured":"Deng Z et al (2020) Let-7f promotes the differentiation of neural stem cells in rats. Am J Transl Res 12(9):5752","journal-title":"Am J Translational Res"},{"issue":"3","key":"1431_CR23","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.3233\/JAD-180201","volume":"64","author":"IHK Dias","year":"2018","unstructured":"Dias IHK et al (2018) miRNA 933 expression by endothelial cells is increased by 27-Hydroxycholesterol and is more prevalent in plasma from Dementia patients. J Alzheimers Dis 64(3):1009\u20131017","journal-title":"J Alzheimers Dis"},{"key":"1431_CR24","doi-asserted-by":"publisher","first-page":"104614","DOI":"10.1016\/j.archger.2021.104614","volume":"99","author":"Y Ding","year":"2022","unstructured":"Ding Y et al (2022) LncRNA BDNF-AS as ceRNA regulates the miR-9-5p\/BACE1 pathway affecting neurotoxicity in Alzheimer\u2019s disease. Arch Gerontol Geriatr 99:104614","journal-title":"Arch Gerontol Geriatr"},{"issue":"7","key":"1431_CR25","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1007\/s12035-021-02323-y","volume":"58","author":"Z Dong","year":"2021","unstructured":"Dong Z et al (2021) Profiling of serum exosome MiRNA reveals the potential of a MiRNA panel as diagnostic biomarker for Alzheimer\u2019s disease. Mol Neurobiol 58(7):3084\u20133094","journal-title":"Mol Neurobiol"},{"key":"1431_CR26","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3389\/fnagi.2016.00078","volume":"8","author":"F Emamian","year":"2016","unstructured":"Emamian F et al (2016) The association between obstructive sleep apnea and Alzheimer\u2019s disease: a meta-analysis perspective. Front Aging Neurosci 8:78","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"1431_CR27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.cell.2007.12.024","volume":"132","author":"A Eulalio","year":"2008","unstructured":"Eulalio A, Huntzinger E, Izaurralde E (2008) Getting to the root of miRNA-mediated gene silencing. Cell 132(1):9\u201314","journal-title":"Cell"},{"key":"1431_CR28","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1146\/annurev-biochem-060308-103103","volume":"79","author":"MR Fabian","year":"2010","unstructured":"Fabian MR, Sonenberg N, Filipowicz W (2010) Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 79:351\u2013379","journal-title":"Annu Rev Biochem"},{"issue":"1","key":"1431_CR29","doi-asserted-by":"publisher","first-page":"15336","DOI":"10.1038\/s41598-019-51703-x","volume":"9","author":"CL Fairchild","year":"2019","unstructured":"Fairchild CL et al (2019) Let-7 regulates cell cycle dynamics in the developing cerebral cortex and retina. Sci Rep 9(1):15336","journal-title":"Sci Rep"},{"issue":"39","key":"1431_CR30","doi-asserted-by":"publisher","first-page":"24213","DOI":"10.1073\/pnas.2008323117","volume":"117","author":"H Geekiyanage","year":"2020","unstructured":"Geekiyanage H et al (2020) Extracellular microRNAs in human circulation are associated with miRISC complexes that are accessible to anti-AGO2 antibody and can bind target mimic oligonucleotides. Proc Natl Acad Sci 117(39):24213\u201324223","journal-title":"Proc Natl Acad Sci"},{"issue":"6","key":"1431_CR31","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1111\/acel.12673","volume":"16","author":"CM Gendron","year":"2017","unstructured":"Gendron CM, Pletcher SD (2017) Micro RNA s mir-184 and let\u20107 alter Drosophila metabolism and longevity. Aging Cell 16(6):1434\u20131438","journal-title":"Aging Cell"},{"issue":"1","key":"1431_CR32","first-page":"109","volume":"113","author":"J Gong","year":"2020","unstructured":"Gong J, Sun D (2020) Study on the mechanism of curcumin to reduce the inflammatory response of temporal lobe in Alzheimer\u2019s disease by regulating miR-146a. Minerva Med 113(1):109\u2013118","journal-title":"Minerva Med"},{"key":"1431_CR33","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3389\/fncel.2013.00178","volume":"7","author":"EF Goodall","year":"2013","unstructured":"Goodall EF et al (2013) Neuronal dark matter: the emerging role of microRNAs in neurodegeneration. Front Cell Neurosci 7:178","journal-title":"Front Cell Neurosci"},{"issue":"3","key":"1431_CR34","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1474-4422(18)30028-0","volume":"17","author":"BA Gordon","year":"2018","unstructured":"Gordon BA et al (2018) Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer\u2019s disease: a longitudinal study. Lancet Neurol 17(3):241\u2013250","journal-title":"Lancet Neurol"},{"key":"1431_CR35","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.neurobiolaging.2020.07.023","volume":"95","author":"JM Gullett","year":"2020","unstructured":"Gullett JM et al (2020) MicroRNA predicts cognitive performance in healthy older adults. Neurobiol Aging 95:186\u2013194","journal-title":"Neurobiol Aging"},{"issue":"5","key":"1431_CR36","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1684\/ejd.2013.2148","volume":"23","author":"S Guo","year":"2013","unstructured":"Guo S et al (2013) Serum and skin levels of mir-369-3p in patients with psoriasis and their correlation with disease severity. Eur J Dermatology 23(5):608\u2013613","journal-title":"Eur J Dermatology"},{"issue":"11","key":"1431_CR37","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.2174\/1567205014666170829101016","volume":"14","author":"P Gupta","year":"2017","unstructured":"Gupta P et al (2017) miRNAs in Alzheimer disease\u2013a therapeutic perspective. Curr Alzheimer Res 14(11):1198\u20131206","journal-title":"Curr Alzheimer Res"},{"key":"1431_CR38","doi-asserted-by":"crossref","unstructured":"Han Z et al (2019) Niclosamide induces cell cycle arrest in G1 phase in head and neck squamous cell carcinoma through Let-7d\/CDC34 axis. Front Pharmacol 9:544","DOI":"10.3389\/fphar.2018.01544"},{"key":"1431_CR39","doi-asserted-by":"crossref","unstructured":"H\u00e9bert SS et al (2008) Loss of microRNA cluster miR-29a\/b-1 in sporadic Alzheimer\u2019s disease correlates with increased BACE1\/\u03b2-secretase expression. Proc Natl Acad Sci 105(17):6415\u20136420","DOI":"10.1073\/pnas.0710263105"},{"issue":"4","key":"1431_CR40","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/(SICI)1098-2264(199812)23:4<350::AID-GCC10>3.0.CO;2-E","volume":"23","author":"U Hirning-Folz","year":"1998","unstructured":"Hirning-Folz U et al (1998) The expression pattern of the hmgic gene during development. Genes Chromosom Cancer 23(4):350\u2013357","journal-title":"Genes Chromosom Cancer"},{"issue":"1","key":"1431_CR41","doi-asserted-by":"publisher","first-page":"62","DOI":"10.29252\/ibj.25.1.62","volume":"25","author":"Z Hojati","year":"2021","unstructured":"Hojati Z et al (2021) The highlighted roles of metabolic and cellular response to stress pathways engaged in circulating hsa-mir-494-3p and hsa-mir-661 in alzheimer\u2019s disease. Iran Biomed J 25(1):62\u201367","journal-title":"Iran Biomed J"},{"key":"1431_CR42","doi-asserted-by":"crossref","unstructured":"Holsinger RD et al (2002) Increased expression of the amyloid precursor \u03b2-secretase in Alzheimer\u2019s disease. Ann Neurol Off J Am Neurol Assoc Child Neurol Soc. 51(6):783\u2013786","DOI":"10.1002\/ana.10208"},{"issue":"7","key":"1431_CR43","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1111\/j.1742-4658.2009.06929.x","volume":"276","author":"CE Hunt","year":"2009","unstructured":"Hunt CE, Turner AJ (2009) Cell biology, regulation and inhibition of \u03b2-secretase (BACE\u20101). FEBS J 276(7):1845\u20131859","journal-title":"FEBS J"},{"issue":"2","key":"1431_CR44","doi-asserted-by":"publisher","first-page":"e1463","DOI":"10.1002\/wrna.1463","volume":"9","author":"ML Idda","year":"2018","unstructured":"Idda ML et al (2018) Noncoding RNAs in Alzheimer\u2019s disease. Wiley Interdiscip Rev RNA 9(2):e1463","journal-title":"Wiley Interdisciplinary Reviews: RNA"},{"issue":"3","key":"1431_CR45","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1002\/jcp.27214","volume":"234","author":"E Iranifar","year":"2019","unstructured":"Iranifar E et al (2019) Exosomes and microRNAs: new potential therapeutic candidates in Alzheimer disease therapy. J Cell Physiol 234(3):2296\u20132305","journal-title":"J Cell Physiol"},{"issue":"4","key":"1431_CR46","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/cbf.3184","volume":"34","author":"LH Jia","year":"2016","unstructured":"Jia LH, Liu YN (2016) Downregulated serum miR-223 servers as biomarker in Alzheimer\u2019s disease. Cell Biochem Funct 34(4):233\u2013237","journal-title":"Cell Biochem Funct"},{"issue":"5","key":"1431_CR47","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.cell.2004.12.038","volume":"120","author":"Q Jing","year":"2005","unstructured":"Jing Q et al (2005) Involvement of microRNA in AU-rich element-mediated mRNA instability. Cell 120(5):623\u2013634","journal-title":"Cell"},{"key":"1431_CR48","doi-asserted-by":"crossref","unstructured":"Kafshdooz T, Farajnia S, Sharifi R, Najmi S (2023) Hsa-let-7\u00a0g-5p, a circulating microRNA, as a biomarker for Alzheimer\u2019s disease. Inf Med Unlocked 38:101203","DOI":"10.1016\/j.imu.2023.101203"},{"issue":"3","key":"1431_CR49","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.bbadis.2015.09.020","volume":"1862","author":"KM Kanninen","year":"2016","unstructured":"Kanninen KM et al (2016) Exosomes as new diagnostic tools in CNS diseases. Biochim Biophys Acta 1862(3):403\u2013410","journal-title":"Biochim Biophys Acta"},{"key":"1431_CR50","doi-asserted-by":"crossref","unstructured":"Kenny A et al (2019a) Elevated plasma microRNA-206 levels predict cognitive decline and progression to dementia from mild cognitive impairment. Biomolecules 9(11):734","DOI":"10.3390\/biom9110734"},{"key":"1431_CR51","doi-asserted-by":"crossref","unstructured":"Kenny A et al (2019b) Elevated plasma microRNA-206 levels predict cognitive decline and progression to dementia from mild cognitive impairment. Biomolecules 9:734","DOI":"10.3390\/biom9110734"},{"issue":"1","key":"1431_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-022-02833-2","volume":"22","author":"S Khalilian","year":"2022","unstructured":"Khalilian S, Hosseini Imani SZ, Ghafouri-Fard S (2022) Emerging roles and mechanisms of miR-206 in human disorders: a comprehensive review. Cancer Cell Int 22(1):1\u201320","journal-title":"Cancer Cell Int"},{"issue":"23","key":"1431_CR53","doi-asserted-by":"publisher","first-page":"17442","DOI":"10.1074\/jbc.M110.107821","volume":"285","author":"N Kosaka","year":"2010","unstructured":"Kosaka N et al (2010) Secretory mechanisms and intercellular transfer of microRNAs in living cells*\u2666. J Biol Chem 285(23):17442\u201317452","journal-title":"J Biol Chem"},{"key":"1431_CR54","doi-asserted-by":"crossref","unstructured":"Kumar S, Reddy PH (2018) MicroRNA-455-3p as a potential biomarker for Alzheimer\u2019s disease: an update. Front Aging Neurosci 10(FEB)","DOI":"10.3389\/fnagi.2018.00041"},{"issue":"s1","key":"1431_CR55","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.3233\/JAD-190583","volume":"72","author":"S Kumar","year":"2019","unstructured":"Kumar S, Reddy PH (2019) A new discovery of MicroRNA-455-3p in Alzheimer\u2019s disease. J Alzheimers Dis 72(s1):S117\u2013s130","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"1431_CR56","doi-asserted-by":"publisher","first-page":"166052","DOI":"10.1016\/j.bbadis.2020.166052","volume":"1867","author":"S Kumar","year":"2021","unstructured":"Kumar S, Reddy PH (2021) Elevated levels of MicroRNA-455-3p in the cerebrospinal fluid of Alzheimer\u2019s patients: a potential biomarker for Alzheimer\u2019s disease. Biochim Biophys Acta Mol Basis Dis 1867(4):166052","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"19","key":"1431_CR57","doi-asserted-by":"publisher","first-page":"3808","DOI":"10.1093\/hmg\/ddx267","volume":"26","author":"S Kumar","year":"2017","unstructured":"Kumar S, Vijayan M, Reddy PH (2017) MicroRNA-455-3p as a potential peripheral biomarker for Alzheimer\u2019s disease. Hum Mol Genet 26(19):3808\u20133822","journal-title":"Hum Mol Genet"},{"issue":"9","key":"1431_CR58","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1016\/j.bbadis.2019.06.006","volume":"1865","author":"S Kumar","year":"2019","unstructured":"Kumar S et al (2019) Novel MicroRNA-455-3p and its protective effects against abnormal APP processing and amyloid beta toxicity in Alzheimer\u2019s disease. Biochim Biophys Acta Mol Basis Dis 1865(9):2428\u20132440","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"1431_CR59","doi-asserted-by":"publisher","first-page":"102182","DOI":"10.1016\/j.redox.2021.102182","volume":"48","author":"S Kumar","year":"2021","unstructured":"Kumar S et al (2021) MicroRNA-455-3p improves synaptic, cognitive functions and extends lifespan: relevance to Alzheimer\u2019s disease. Redox Biol 48:102182","journal-title":"Redox Biol"},{"issue":"20","key":"1431_CR60","doi-asserted-by":"publisher","first-page":"4051","DOI":"10.1038\/sj.emboj.7600385","volume":"23","author":"Y Lee","year":"2004","unstructured":"Lee Y et al (2004) MicroRNA genes are transcribed by RNA polymerase II. EMBO J 23(20):4051\u20134060","journal-title":"EMBO J"},{"issue":"2","key":"1431_CR61","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/ana.23588","volume":"72","author":"ST Lee","year":"2012","unstructured":"Lee ST et al (2012) miR-206 regulates brain\u2010derived neurotrophic factor in Alzheimer disease model. Ann Neurol 72(2):269\u2013277","journal-title":"Ann Neurol"},{"key":"1431_CR62","doi-asserted-by":"crossref","unstructured":"Lee BK, Kim MH, Lee SY, Son SJ, Hong CH, Jung YS (2020) Downregulated platelet MiR-1233-5p in patients with alzheimer\u2019s pathologic change with mild cognitive impairment is associated with a\u03b2-induced platelet activation via p-selectin. J Clin Med 9(6):1642","DOI":"10.3390\/jcm9061642"},{"issue":"7","key":"1431_CR63","doi-asserted-by":"publisher","first-page":"R78","DOI":"10.1186\/gb-2013-14-7-r78","volume":"14","author":"P Leidinger","year":"2013","unstructured":"Leidinger P et al (2013) A blood based 12-miRNA signature of Alzheimer disease patients. Genome Biol 14(7):R78","journal-title":"Genome Biol"},{"key":"1431_CR64","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1748-5908-5-69","volume":"5","author":"D Levac","year":"2010","unstructured":"Levac D, Colquhoun H, O'Brien KK(2010)Scoping studies: advancing the methodology. Implement Sci 5:69","journal-title":"Implement Sci"},{"key":"1431_CR65","doi-asserted-by":"crossref","unstructured":"Li Q et al (2019a) MicroRNA-101a regulates autophagy phenomenon via the MAPK pathway to modulate Alzheimer\u2019s-associated pathogenesis. Cell Transplant 28(8):1076\u20131084","DOI":"10.1177\/0963689719857085"},{"issue":"4","key":"1431_CR66","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1177\/0891988719835325","volume":"32","author":"K-X Li","year":"2019","unstructured":"Li K-X et al (2019b) ER\u03b1 gene promoter methylation in cognitive function and quality of life of patients with Alzheimer disease. J Geriatr Psychiatr Neurol 32(4):221\u2013228","journal-title":"J Geriatr Psychiatr Neurol"},{"key":"1431_CR67","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.neuroscience.2020.02.044","volume":"432","author":"F Li","year":"2020","unstructured":"Li F et al (2020) Profile of pathogenic proteins and MicroRNAs in plasma-derived Extracellular vesicles in Alzheimer\u2019s Disease: a pilot study. Neuroscience 432:240\u2013246","journal-title":"Neuroscience"},{"key":"1431_CR68","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.brainres.2014.04.026","volume":"1583","author":"C-g Liu","year":"2014","unstructured":"Liu C-g et al (2014) MicroRNA-135a and-200b, potential biomarkers for Alzheimer\u05f3 s disease, regulate \u03b2 secretase and amyloid precursor protein. Brain Res 1583:55\u201364","journal-title":"Brain Res"},{"issue":"11","key":"1431_CR69","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1080\/09168451.2020.1797469","volume":"84","author":"J Liu","year":"2020","unstructured":"Liu J et al (2020a) MiR-9-5p inhibits mitochondrial damage and oxidative stress in AD cell models by targeting GSK-3\u03b2. Biosci Biotechnol Biochem 84(11):2273\u20132280","journal-title":"Biosci Biotechnol Biochem"},{"key":"1431_CR70","doi-asserted-by":"publisher","first-page":"601965","DOI":"10.3389\/fnagi.2020.601965","volume":"12","author":"L Liu","year":"2020","unstructured":"Liu L et al (2020b) Identification of circular RNA hsa_Circ_0003391 in peripheral blood is potentially associated with Alzheimer\u2019s disease. Front Aging Neurosci 12:601965","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"1431_CR71","first-page":"19","volume":"34","author":"CG Liu","year":"2021","unstructured":"Liu CG et al (2021) MicroRNA-135a in ABCA1-labeled exosome is a serum biomarker candidate for Alzheimer\u2019s disease. Biomed Environ Sci 34(1):19\u201328","journal-title":"Biomed Environ Sci"},{"key":"1431_CR72","doi-asserted-by":"publisher","first-page":"112681","DOI":"10.1016\/j.biopha.2022.112681","volume":"148","author":"S Liu","year":"2022","unstructured":"Liu S et al (2022a) MicroRNAs in Alzheimer\u2019s disease: potential diagnostic markers and therapeutic targets. Biomed Pharmacother 148:112681","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"1431_CR73","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3892\/etm.2022.11166","volume":"23","author":"Y Liu","year":"2022","unstructured":"Liu Y, Xu Y, Yu M (2022b) MicroRNA-4722-5p and microRNA-615-3p serve as potential biomarkers for Alzheimer\u2019s disease. Exp Ther Med 23(3):241","journal-title":"Exp Ther Med"},{"key":"1431_CR74","doi-asserted-by":"crossref","unstructured":"Liu X et al (2024) SIRT1 and miR-34a-5p expression in PBMCs as potential biomarkers for patients with type 2 diabetes with cognitive impairments. J Clin Endocrinol Metab 109(3):815\u2013826","DOI":"10.1210\/clinem\/dgad562"},{"issue":"8","key":"1431_CR75","doi-asserted-by":"publisher","first-page":"5184","DOI":"10.1074\/jbc.M113.518241","volume":"289","author":"JM Long","year":"2014","unstructured":"Long JM, Ray B, Lahiri DK (2014) MicroRNA-339-5p down-regulates protein expression of \u03b2-site amyloid precursor protein-cleaving enzyme 1 (BACE1) in human primary brain cultures and is reduced in brain tissue specimens of Alzheimer disease subjects. J Biol Chem 289(8):5184\u20135198","journal-title":"J Biol Chem"},{"issue":"4","key":"1431_CR76","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.gpb.2019.09.004","volume":"17","author":"N Ludwig","year":"2019","unstructured":"Ludwig N et al (2019) Machine learning to detect Alzheimer\u2019s disease from circulating non-coding RNAs. Genomics Proteom Bioinf 17(4):430\u2013440","journal-title":"Genomics Proteom Bioinf"},{"issue":"3","key":"1431_CR77","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/WNR.0b013e3280148e8b","volume":"18","author":"WJ Lukiw","year":"2007","unstructured":"Lukiw WJ (2007) Micro-RNA speciation in fetal, adult and Alzheimer\u2019s disease hippocampus. NeuroReport 18(3):297\u2013300","journal-title":"NeuroReport"},{"issue":"3","key":"1431_CR78","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.3233\/JAD-160835","volume":"55","author":"TA Lusardi","year":"2017","unstructured":"Lusardi TA et al (2017) MicroRNAs in human cerebrospinal fluid as biomarkers for Alzheimer\u2019s Disease. J Alzheimers Dis 55(3):1223\u20131233","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"1431_CR79","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1093\/intimm\/dxx015","volume":"29","author":"K Maeda","year":"2017","unstructured":"Maeda K, Akira S (2017) Regulation of mRNA stability by CCCH-type zinc-finger proteins in immune cells. Int Immunol 29(4):149\u2013155","journal-title":"Int Immunol"},{"key":"1431_CR80","doi-asserted-by":"crossref","unstructured":"Manna I et al (2020) Exosomal miRNAs as potential diagnostic biomarkers in Alzheimer\u2019s Disease. Pharmaceuticals (Basel) 13(9)","DOI":"10.3390\/ph13090243"},{"issue":"3","key":"1431_CR81","doi-asserted-by":"publisher","first-page":"e1627","DOI":"10.1002\/wrna.1627","volume":"12","author":"JC Medley","year":"2021","unstructured":"Medley JC, Panzade G, Zinovyeva AY (2021) microRNA strand selection: unwinding the rules. Wiley Interdisciplinary Reviews: RNA 12(3):e1627","journal-title":"Wiley Interdisciplinary Reviews: RNA"},{"key":"1431_CR82","first-page":"449","volume-title":"The temporal lobe in typical and atypical Alzheimer disease, in Handbook of Clinical Neurology","author":"R Migliaccio","year":"2022","unstructured":"Migliaccio R, Cacciamani F (2022) The temporal lobe in typical and atypical Alzheimer disease, in Handbook of Clinical Neurology. Elsevier, pp 449\u2013466"},{"issue":"1","key":"1431_CR83","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.oraloncology.2011.11.006","volume":"48","author":"J Minor","year":"2012","unstructured":"Minor J et al (2012) Methylation of microRNA-9 is a specific and sensitive biomarker for oral and oropharyngeal squamous cell carcinomas. Oral Oncol 48(1):73\u201378","journal-title":"Oral Oncol"},{"issue":"1","key":"1431_CR84","doi-asserted-by":"publisher","first-page":"15","DOI":"10.18632\/oncotarget.13905","volume":"8","author":"M Mo","year":"2017","unstructured":"Mo M et al (2017) MicroRNA expressing profiles in A53T mutant alpha-synuclein transgenic mice and parkinsonian. Oncotarget 8(1):15","journal-title":"Oncotarget"},{"issue":"1","key":"1431_CR85","doi-asserted-by":"publisher","first-page":"20364","DOI":"10.1038\/srep20364","volume":"6","author":"J Moon","year":"2016","unstructured":"Moon J et al (2016) Early diagnosis of Alzheimer\u2019s disease from elevated olfactory mucosal miR-206 level. Sci Rep 6(1):20364","journal-title":"Sci Rep"},{"key":"1431_CR86","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1007\/s12035-015-9156-8","volume":"53","author":"M M\u00fcller","year":"2016","unstructured":"M\u00fcller M et al (2016) MicroRNA-29a is a candidate biomarker for Alzheimer\u2019s disease in cell-free cerebrospinal fluid. Mol Neurobiol 53:2894\u20132899","journal-title":"Mol Neurobiol"},{"key":"1431_CR87","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.arr.2018.10.008","volume":"49","author":"S Nagaraj","year":"2019","unstructured":"Nagaraj S et al (2019) microRNA diagnostic panel for Alzheimer\u2019s disease and epigenetic trade-off between neurodegeneration and cancer. Ageing Res Rev 49:125\u2013143","journal-title":"Ageing Res Rev"},{"issue":"1","key":"1431_CR88","doi-asserted-by":"publisher","first-page":"18884","DOI":"10.1038\/s41598-022-21132-4","volume":"12","author":"VW Nakao","year":"2022","unstructured":"Nakao VW et al (2022) Neuroprotective action of \u03b1-Klotho against LPS-activated glia conditioned medium in primary neuronal culture. Sci Rep 12(1):18884","journal-title":"Sci Rep"},{"issue":"1","key":"1431_CR89","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/cdev.12014","volume":"84","author":"OY Naumova","year":"2013","unstructured":"Naumova OY et al (2013) Gene expression in the human brain: the current state of the study of specificity and spatiotemporal dynamics. Child Dev 84(1):76\u201388","journal-title":"Child Dev"},{"key":"1431_CR90","first-page":"1500","volume":"10","author":"M Nik","year":"2019","unstructured":"Nik M, Kamal N, Shahidan WNS (2019) Non-exosomal and exosomal circulatory MicroRNAs: which are more valid as biomarkers? Front Pharmacol 10:1500","journal-title":"Front Pharmacol"},{"issue":"21","key":"1431_CR91","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.4161\/cc.6.21.4845","volume":"6","author":"S-M Park","year":"2007","unstructured":"Park S-M et al (2007) Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2. Cell Cycle 6(21):2585\u20132590","journal-title":"Cell Cycle"},{"issue":"5","key":"1431_CR92","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.7150\/ijbs.66604","volume":"18","author":"H Park","year":"2022","unstructured":"Park H, Lee YB, Chang KA (2022) miR-200c suppression increases tau hyperphosphorylation by targeting 14-3-3\u03b3 in early stage of 5xFAD mouse model of Alzheimer\u2019s disease. Int J Biol Sci 18(5):2220\u20132234","journal-title":"Int J Biol Sci"},{"key":"1431_CR93","first-page":"162","volume-title":"Two-stage Bayesian GWAS of 9576 individuals identifies SNP regions that are targeted by miRNAs inversely expressed in Alzheimer's and cancer","author":"GA Pathak","year":"2020","unstructured":"Pathak GA et al (2020) Two-stage Bayesian GWAS of 9576 individuals identifies SNP regions that are targeted by miRNAs inversely expressed in Alzheimer\u2019s and cancer, vol 16. Alzheimer\u2019s & Dementia, pp 162\u2013177. 1"},{"issue":"1","key":"1431_CR94","doi-asserted-by":"publisher","first-page":"15589","DOI":"10.1038\/s41598-022-19862-6","volume":"12","author":"C Pe\u00f1a-Bautista","year":"2022","unstructured":"Pe\u00f1a-Bautista C et al (2022) Plasma microRNAs as potential biomarkers in early Alzheimer disease expression. Sci Rep 12(1):15589","journal-title":"Sci Rep"},{"key":"1431_CR95","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.neurobiolaging.2016.09.019","volume":"50","author":"S Pichler","year":"2017","unstructured":"Pichler S et al (2017) The miRNome of Alzheimer\u2019s disease: consistent downregulation of the miR-132\/212 cluster. Neurobiol Aging 50:167e1-167. e10","journal-title":"Neurobiol Aging"},{"key":"1431_CR96","doi-asserted-by":"crossref","unstructured":"Pi\u00f1ol Ripoll G et al (2019) Prevalence of obstructive sleep apnea in Alzheimer\u2019s disease patients. J Neurol 267(4):1012\u20131022","DOI":"10.1007\/s00415-019-09668-4"},{"issue":"1","key":"1431_CR97","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/YPG.0000000000000303","volume":"32","author":"E Poursaei","year":"2022","unstructured":"Poursaei E et al (2022) Evaluation of hsa-let-7d-5p, hsa-let-7\u00a0g-5p and hsa-miR-15b-5p plasma levels in patients with Alzheimer\u2019s disease. Psychiatr Genet 32(1):25\u201329","journal-title":"Psychiatr Genet"},{"issue":"1\u20132","key":"1431_CR98","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0378-1119(01)00689-8","volume":"277","author":"R Reeves","year":"2001","unstructured":"Reeves R (2001) Molecular biology of HMGA proteins: hubs of nuclear function. Gene 277(1\u20132):63\u201381","journal-title":"Gene"},{"key":"1431_CR99","doi-asserted-by":"publisher","first-page":"5772","DOI":"10.1007\/s12035-015-9484-8","volume":"53","author":"R-J Ren","year":"2016","unstructured":"Ren R-J et al (2016) Peripheral blood microRNA expression profiles in Alzheimer\u2019s disease: screening, validation, association with clinical phenotype and implications for molecular mechanism. Mol Neurobiol 53:5772\u20135781","journal-title":"Mol Neurobiol"},{"issue":"2","key":"1431_CR100","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3233\/JAD-161179","volume":"57","author":"J Riancho","year":"2017","unstructured":"Riancho J et al (2017) MicroRNA profile in patients with Alzheimer\u2019s disease: analysis of mir-9-5p and miR-598 in raw and exosome enriched cerebrospinal fluid samples. J Alzheimers Dis 57(2):483\u2013491","journal-title":"J Alzheimers Dis"},{"key":"1431_CR101","doi-asserted-by":"crossref","unstructured":"Roberts E, Cossigny DA, Quan GM (2013) The role of vascular endothelial growth factor in metastatic prostate cancer to the skeleton. Prostate Cancer\u00a02013(1):418340","DOI":"10.1155\/2013\/418340"},{"key":"1431_CR102","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/bs.pbr.2015.04.013","volume":"220","author":"GL Romano","year":"2015","unstructured":"Romano GL et al (2015) MicroRNA target prediction in glaucoma. Prog Brain Res 220:217\u2013240","journal-title":"Prog Brain Res"},{"key":"1431_CR103","doi-asserted-by":"crossref","unstructured":"Sabaie H et al (2022) Identification and analysis of BCAS4\/hsa-miR-185-5p\/SHISA7 competing endogenous RNA Axis in Late-Onset Alzheimer\u2019s disease using bioinformatic and experimental approaches. Front Aging Neurosci 14","DOI":"10.3389\/fnagi.2022.812169"},{"issue":"1","key":"1431_CR104","doi-asserted-by":"publisher","first-page":"230","DOI":"10.14283\/jpad.2023.99","volume":"11","author":"A Sadlon","year":"2024","unstructured":"Sadlon A et al (2024) Association of Blood MicroRNA expression and polymorphisms with cognitive and biomarker changes in older adults. J Prev Alzheimer\u2019s Disease 11(1):230\u2013240","journal-title":"J Prev Alzheimer\u2019s Disease"},{"issue":"3","key":"1431_CR105","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.it.2020.01.001","volume":"41","author":"F Salerno","year":"2020","unstructured":"Salerno F, Turner M, Wolkers MC (2020) Dynamic post-transcriptional events governing CD8\u2009+\u2009T cell homeostasis and effector function. Trends Immunol 41(3):240\u2013254","journal-title":"Trends Immunol"},{"key":"1431_CR106","first-page":"GRSB","volume":"1","author":"HM Schipper","year":"2007","unstructured":"Schipper HM et al (2007) MicroRNA expression in Alzheimer blood mononuclear cells. Gene Regul Syst Biology 1:GRSB","journal-title":"Gene Regul Syst Biology"},{"key":"1431_CR107","doi-asserted-by":"publisher","first-page":"3543","DOI":"10.1007\/s00018-012-1125-z","volume":"69","author":"N Schonrock","year":"2012","unstructured":"Schonrock N, G\u00f6tz J (2012) Decoding the non-coding RNAs in Alzheimer\u2019s disease. Cell Mol Life Sci 69:3543\u20133559","journal-title":"Cell Mol Life Sci"},{"key":"1431_CR108","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s12031-019-01345-5","volume":"69","author":"M Sedighi","year":"2019","unstructured":"Sedighi M et al (2019) Klotho ameliorates cellular inflammation via suppression of cytokine release and upregulation of miR-29a in the PBMCs of diagnosed Alzheimer\u2019s disease patients. J Mol Neurosci 69:157\u2013165","journal-title":"J Mol Neurosci"},{"key":"1431_CR109","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/gb-2004-5-3-r13","volume":"5","author":"LF Sempere","year":"2004","unstructured":"Sempere LF et al (2004) Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol 5:1\u201311","journal-title":"Genome Biol"},{"issue":"4","key":"1431_CR110","doi-asserted-by":"publisher","first-page":"787","DOI":"10.3233\/JAD-2011-110074","volume":"26","author":"M Serpente","year":"2011","unstructured":"Serpente M et al (2011) Role of OLR1 and its regulating hsa-miR369-3p in Alzheimer\u2019s disease: genetics and expression analysis. J Alzheimers Dis 26(4):787\u2013793","journal-title":"J Alzheimers Dis"},{"key":"1431_CR111","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1007\/s12035-015-9145-y","volume":"53","author":"Shamsuzzama","year":"2016","unstructured":"Shamsuzzama et al (2016) Role of microRNA Let-7 in modulating multifactorial aspect of neurodegenerative diseases: an overview. Mol Neurobiol 53:2787\u20132793","journal-title":"Mol Neurobiol"},{"key":"1431_CR112","unstructured":"Siitonen A (2020) Genetics of Parkinson\u2019s disease in Finland"},{"key":"1431_CR113","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s12017-012-8183-0","volume":"14","author":"M Sinha","year":"2012","unstructured":"Sinha M, Mukhopadhyay S, Bhattacharyya NP (2012) Mechanism (s) of alteration of micro RNA expressions in Huntington\u2019s disease and their possible contributions to the observed cellular and molecular dysfunctions in the disease. Neuromol Med 14:221\u2013243","journal-title":"Neuromol Med"},{"issue":"1","key":"1431_CR114","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000080963","volume":"19","author":"SB Solerte","year":"2004","unstructured":"Solerte SB et al (2004) Decreased release of the angiogenic peptide vascular endothelial growth factor in Alzheimer\u2019s disease: recovering effect with insulin and DHEA sulfate. Dement Geriatr Cogn Disord 19(1):1\u201310","journal-title":"Dement Geriatr Cogn Disord"},{"key":"1431_CR115","doi-asserted-by":"publisher","unstructured":"S\u00f8rensen SS, Nygaard AB, Christensen T (2016) miRNA expression profiles in cerebrospinal fluid and blood of patients with Alzheimer\u2019s disease and other types of dementia - an exploratory study. Transl Neurodegen 5:6. https:\/\/doi.org\/10.1186\/s40035-016-0053-5","DOI":"10.1186\/s40035-016-0053-5"},{"key":"1431_CR116","doi-asserted-by":"publisher","first-page":"153331752091157","DOI":"10.1177\/1533317520911573","volume":"35","author":"VC Souza","year":"2020","unstructured":"Souza VC et al (2020) Whole-blood levels of MicroRNA-9 are decreased in patients with late-onset Alzheimer disease. Am J Alzheimer\u2019s Disease Other Dementias\u00ae 35:1533317520911573","journal-title":"Am J Alzheimer\u2019s Disease Other Dementias\u00ae"},{"issue":"1","key":"1431_CR117","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/WNR.0000000000000032","volume":"25","author":"Y Su","year":"2014","unstructured":"Su Y et al (2014) MiR-200a impairs glioma cell growth, migration, and invasion by targeting SIM2-s. NeuroReport 25(1):12\u201317","journal-title":"NeuroReport"},{"issue":"4","key":"1431_CR118","first-page":"2365","volume":"37","author":"W Su","year":"2021","unstructured":"Su W et al (2021) Genetic polymorphism of serum exosome-associated micrornas in patients with alzheimers disease. Acta Med Mediterranea 37(4):2365\u20132370","journal-title":"ACTA Med MEDITERRANEA"},{"issue":"3","key":"1431_CR119","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.tcm.2013.09.002","volume":"24","author":"X Sun","year":"2014","unstructured":"Sun X, Sit A, Feinberg MW (2014) Role of miR-181 family in regulating vascular inflammation and immunity. Trends Cardiovasc Med 24(3):105\u2013112","journal-title":"Trends Cardiovasc Med"},{"key":"1431_CR120","doi-asserted-by":"crossref","unstructured":"Takousis P et al (2019) Differential expression of microRNAs in Alzheimer\u2019s disease brain, blood, and cerebrospinal fluid. Alzheimer\u2019s Dementia 15(11):1468\u20131477","DOI":"10.1016\/j.jalz.2019.06.4952"},{"issue":"11","key":"1431_CR121","doi-asserted-by":"publisher","first-page":"4363","DOI":"10.1007\/s12035-020-02031-z","volume":"57","author":"A Targa","year":"2020","unstructured":"Targa A et al (2020) Circulating MicroRNA profile associated with obstructive sleep apnea in Alzheimer\u2019s disease. Mol Neurobiol 57(11):4363\u20134372","journal-title":"Mol Neurobiol"},{"issue":"7","key":"1431_CR122","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC et al (2018) PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med 169(7):467\u2013473","journal-title":"Ann Intern Med"},{"key":"1431_CR123","doi-asserted-by":"crossref","unstructured":"Tsamou M et al (2023) A candidate microRNA profile for early diagnosis of sporadic Alzheimer\u2019s Disease. J Alzheimer\u2019s Disease Rep, (Preprint): p. 1\u201314","DOI":"10.3233\/ADR-230001"},{"key":"1431_CR124","doi-asserted-by":"publisher","first-page":"101732","DOI":"10.1016\/j.pneurobio.2019.101732","volume":"185","author":"M Van den Berg","year":"2020","unstructured":"Van den Berg M et al (2020) Circulating microRNAs as potential biomarkers for psychiatric and neurodegenerative disorders. Prog Neurobiol 185:101732","journal-title":"Prog Neurobiol"},{"issue":"4","key":"1431_CR125","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/ncb2210","volume":"13","author":"KC Vickers","year":"2011","unstructured":"Vickers KC et al (2011) MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 13(4):423\u2013433","journal-title":"Nat Cell Biol"},{"issue":"3","key":"1431_CR126","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1089\/rej.2010.1123","volume":"14","author":"C Villa","year":"2011","unstructured":"Villa C et al (2011) Role of hnRNP-A1 and mir-590-3p in neuronal death: genetics and expression analysis in patients with Alzheimer disease and frontotemporal lobar degeneration. Rejuven Res 14(3):275\u2013281","journal-title":"Rejuven Res"},{"issue":"3","key":"1431_CR127","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3233\/JAD-122263","volume":"35","author":"C Villa","year":"2013","unstructured":"Villa C et al (2013) Expression of the transcription factor Sp1 and its regulatory hsa-miR-29b in peripheral blood mononuclear cells from patients with Alzheimer\u2019s disease. J Alzheimers Dis 35(3):487\u2013494","journal-title":"J Alzheimers Dis"},{"issue":"19","key":"1431_CR128","doi-asserted-by":"publisher","first-page":"14749","DOI":"10.3390\/ijms241914749","volume":"24","author":"C Visconte","year":"2023","unstructured":"Visconte C et al (2023) Altered extracellular vesicle miRNA profile in prodromal Alzheimer\u2019s disease. Int J Mol Sci 24(19):14749","journal-title":"Int J Mol Sci"},{"issue":"7","key":"1431_CR129","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1002\/gps.4881","volume":"33","author":"Z Wang","year":"2018","unstructured":"Wang Z et al (2018) The microRNA-1908 up-regulation in the peripheral blood cells impairs amyloid clearance by targeting ApoE. Int J Geriatr Psychiatry 33(7):980\u2013986","journal-title":"Int J Geriatr Psychiatry"},{"key":"1431_CR130","doi-asserted-by":"publisher","unstructured":"Wang J, Chen C, Zhang Y (2020) An investigation of microRNA-103 and microRNA-107 as potential blood-based biomarkers for disease risk and progression of Alzheimer\u2019s disease. J Clin Lab Anal 34(1):e23006. https:\/\/doi.org\/10.1002\/jcla.23006","DOI":"10.1002\/jcla.23006"},{"issue":"1","key":"1431_CR131","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1186\/s12891-023-07003-7","volume":"24","author":"D Wang","year":"2023","unstructured":"Wang D et al (2023) Upregulating miR-181b promotes ferroptosis in osteoarthritic chondrocytes by inhibiting SLC7A11. BMC Musculoskelet Disord 24(1):862","journal-title":"BMC Musculoskelet Disord"},{"issue":"1","key":"1431_CR132","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1080\/07853890.2022.2077428","volume":"54","author":"S-E Wu","year":"2022","unstructured":"Wu S-E, Chen W-L (2022) Soluble klotho as an effective biomarker to characterize inflammatory states. Ann Med 54(1):1520\u20131529","journal-title":"Ann Med"},{"issue":"3","key":"1431_CR133","doi-asserted-by":"publisher","first-page":"755","DOI":"10.3233\/JAD-150619","volume":"49","author":"HZY Wu","year":"2016","unstructured":"Wu HZY et al (2016) Circulating microRNAs as biomarkers of Alzheimer\u2019s disease: a systematic review. J Alzheimers Dis 49(3):755\u2013766","journal-title":"J Alzheimers Dis"},{"key":"1431_CR134","doi-asserted-by":"crossref","unstructured":"Xia X, Ahmad I (2016) let-7 microRNA regulates neurogliogenesis in the mammalian retina through Hmga2. Dev Biol 410(1):70\u201385","DOI":"10.1016\/j.ydbio.2015.12.010"},{"issue":"3","key":"1431_CR135","doi-asserted-by":"publisher","first-page":"721","DOI":"10.3233\/JAD-142847","volume":"45","author":"B Xie","year":"2015","unstructured":"Xie B et al (2015) Serum miR-206 and miR-132 as potential circulating biomarkers for mild cognitive impairment. J Alzheimers Dis 45(3):721\u2013731","journal-title":"J Alzheimers Dis"},{"key":"1431_CR136","doi-asserted-by":"crossref","unstructured":"Xie T et al (2022) Identification of miRNA-mRNA pairs in the Alzheimer\u2019s disease expression profile and explore the effect of miR-26a-5p\/PTGS2 on Amyloid-\u03b2 induced neurotoxicity in Alzheimer\u2019s disease cell model. Front Aging Neurosci 14:909222","DOI":"10.3389\/fnagi.2022.909222"},{"issue":"11","key":"1431_CR137","doi-asserted-by":"publisher","first-page":"15538","DOI":"10.18632\/aging.203114","volume":"13","author":"Y Xu","year":"2021","unstructured":"Xu Y et al (2021) miR-34a inhibits melanoma growth by targeting ZEB1. Aging 13(11):15538","journal-title":"Aging"},{"key":"1431_CR138","doi-asserted-by":"publisher","first-page":"108583","DOI":"10.1016\/j.biopha.2019.01.044","volume":"112","author":"L Yan","year":"2019","unstructured":"Yan L et al (2019) The role of microRNA-16 in the pathogenesis of autoimmune diseases: a comprehensive review. Biomed Pharmacother 112:108583","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"1431_CR139","first-page":"87","volume":"31","author":"TT Yang","year":"2018","unstructured":"Yang TT et al (2018) The serum exosome derived MicroRNA-135a, -193b, and\u2013\u2009384 were potential Alzheimer\u2019s disease biomarkers. Biomed Environ Sci 31(2):87\u201396","journal-title":"Biomed Environ Sci"},{"issue":"8","key":"1431_CR140","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1089\/omi.2016.0099","volume":"20","author":"\u015eG Y\u0131lmaz","year":"2016","unstructured":"Y\u0131lmaz \u015eG et al (2016) Can peripheral MicroRNA expression data serve as epigenomic (upstream) biomarkers of Alzheimer\u2019s disease? OMICS 20(8):456\u2013461","journal-title":"OMICS"},{"key":"1431_CR141","first-page":"e1548","volume-title":"MiR-485-3p serves as a biomarker and therapeutic target of Alzheimer's disease via regulating neuronal cell viability and neuroinflammation by targeting AKT3","author":"L Yu","year":"2021","unstructured":"Yu L et al (2021) MiR-485-3p serves as a biomarker and therapeutic target of Alzheimer\u2019s disease via regulating neuronal cell viability and neuroinflammation by targeting AKT3. Mol Gen Genom Med 9(1):e1548"},{"issue":"3","key":"1431_CR142","doi-asserted-by":"publisher","first-page":"e4722","DOI":"10.1371\/journal.pone.0004722","volume":"4","author":"A Yuan","year":"2009","unstructured":"Yuan A et al (2009) Transfer of microRNAs by embryonic stem cell microvesicles. PLoS ONE 4(3):e4722","journal-title":"PLoS ONE"},{"issue":"4","key":"1431_CR143","doi-asserted-by":"publisher","first-page":"557","DOI":"10.4161\/rna.8.4.16019","volume":"8","author":"Y Yuva-Aydemir","year":"2011","unstructured":"Yuva-Aydemir Y et al (2011) MicroRNA-9: functional evolution of a conserved small regulatory RNA. RNA Biol 8(4):557\u2013564","journal-title":"RNA Biol"},{"key":"1431_CR144","doi-asserted-by":"crossref","unstructured":"Zhang H et al (2021) Aberrant expression of miR-148a-3p in Alzheimer\u2019s disease and its protective role against amyloid-\u03b2 induced neurotoxicity. Neurosci Lett 756","DOI":"10.1016\/j.neulet.2021.135953"},{"issue":"1","key":"1431_CR145","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1373\/jalm.2019.029595","volume":"5","author":"X Zhao","year":"2020","unstructured":"Zhao X et al (2020) A machine learning approach to identify a circulating MicroRNA signature for Alzheimer disease. J Appl Lab Med 5(1):15\u201328","journal-title":"J Appl Lab Med"},{"key":"1431_CR146","doi-asserted-by":"crossref","unstructured":"Zheng K et al (2021) miR-135a-5p mediates memory and synaptic impairments via the Rock2\/Adducin1 signaling pathway in a mouse model of Alzheimer\u2019s disease. Nat Commun 12(1):1903","DOI":"10.1038\/s41467-021-22196-y"},{"key":"1431_CR147","doi-asserted-by":"crossref","unstructured":"Zhou H et al (2022) miR-181b regulates vascular endothelial aging by modulating a MAP3K3 signaling pathway. FASEB J Off Pub Fed Am Soc Exp Biol 36(6):e22353","DOI":"10.1096\/fj.202200046R"},{"key":"1431_CR148","doi-asserted-by":"crossref","unstructured":"Zhu Y et al (2015) Quantification of microRNA-210 in the cerebrospinal fluid and serum: implications for Alzheimer\u2019s disease. Exp Ther Med 9(3):1013\u20131017","DOI":"10.3892\/etm.2015.2179"},{"key":"1431_CR149","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.brainres.2011.04.035","volume":"1395","author":"Y Zong","year":"2011","unstructured":"Zong Y et al (2011) miR-29c regulates BACE1 protein expression. Brain Res 1395:108\u2013115","journal-title":"Brain Res"},{"issue":"20","key":"1431_CR150","doi-asserted-by":"publisher","first-page":"4299","DOI":"10.1038\/emboj.2011.327","volume":"30","author":"A Zovoilis","year":"2011","unstructured":"Zovoilis A et al (2011) microRNA-34c is a novel target to treat dementias. EMBO J 30(20):4299\u20134308","journal-title":"EMBO J"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-024-01431-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-024-01431-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-024-01431-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T06:00:56Z","timestamp":1740549656000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-024-01431-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,28]]},"references-count":150,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["1431"],"URL":"https:\/\/doi.org\/10.1007\/s11011-024-01431-7","relation":{},"ISSN":["1573-7365"],"issn-type":[{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,28]]},"assertion":[{"value":"20 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Kindly note that this study is a systematic review, which, by its nature, does not involve direct interaction with human subjects, animals, or the collection of primary data. Therefore, ethical approval was not pursued for this review. The research methodology adheres to ethical considerations, as it focuses on a comprehensive synthesis and analysis of previously published and publicly available information. This approach ensures alignment with ethical standards and guidelines, while providing valuable insights into the existing body of knowledge on the subject. Your understanding and consideration regarding this matter are sincerely appreciated.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"44"}}